VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
USNA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
USNAUSANA Health Sciences, Inc.
$13.63$252M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
USNA logo

USANA Health Sciences, Inc.

USNA
NYSE · Packaged Foods
$13.63
At close - Nov 6, 4:00 PM EST - USD
Market Cap$252M
P/E-11.9x
52W High$23.59
Volume292.32K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q2

Margin Reset Fails To Offset Structural Revenue Erosion

USANA Health Sciences presents a deeply discounted valuation story—trading at 0.45x book and 1.27x EV/EBITDA with a forward P/E of 8.09—yet the fundamental picture warrants caution before treating the discount as an opportunity.

GrowthMixed
ProfitabilityStrained
ValuationExpensive
TechnicalsWeak
Explore valuation models
MARKET ACTION

USNA price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

8/12 Beats

EPS beat 8 of last 12 quarters

02

Valuation risk

-161% Peers

P/E is 161% below peer median

03

Market leadership

RS 29 · Lag

Laggard (Underperforming 71% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystEstimated earnings · Feb 3

Market performance

Price History →

Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
USNA-29.89%
S&P 500 (^GSPC)+7.63%
1-Year Return
USNA-28.86%
S&P 500 (^GSPC)+9.69%
3-Year Return
USNA-70.64%
S&P 500 (^GSPC)+67.19%
5-Year Return
USNA-86.52%
S&P 500 (^GSPC)+55.20%
02

Test the fundamentals

Check whether operating performance supports the current valuation.

VALUATION & INTRINSIC VALUE

Valuation Scenarios

Valuation Analysis
Trailing P/E5Y Low
-11.9x
Forward P/E
7.8x
EV/EBITDA20th %ile
2.4x
FCF YieldCash Flow
3.4%

Valuation vs 5-Year History

Multiple Range
Metric
Current
5Y Median
Historical Range
Percentile
P/E
-11.9x
16.3x
0th· Low
EV/EBITDA
2.4x
6.1x
20th· Low
Price/FCF
29.5x
18.5x
80th· High
Current Multiple
5Y Median (50th %ile)

Intrinsic Value Scenarios

DCF Projection
No DCF Model AvailableIntrinsic value modeling is not supported for this equity.

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$925M+8.3% YoY
Net income FY25
$11M-74.4% YoY
Free cash flow FY25
$9M-83.3% YoY
Operating margin FY25
5.5%-2.3 pts YoY
ROIC (FY25)8.6%
Avg ROIC 5Y38.7%
ROE (TTM)-3.7%
Piotroski Score7 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate8/12 (67%)
Revenue Beat Rate7/12 (58%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Nov 3, 2026
-$0.11-200.0%
vs $0.11
$206M-5.3%
vs $217M
Q3 2026
Aug 4, 2026
-$0.07-116.3%
vs $0.43
$223M-5.0%
vs $235M
Q2 2026
May 5, 2026
$0.61+38.6%
vs $0.44
$250M+3.7%
vs $241M
Q1 2026
Feb 17, 2026
$0.60+46.3%
vs $0.41
$226M+0.1%
vs $226M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Business Wire·Oct 12, 2026
USANA Schedules Third Quarter 2026 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that third quarter 2026 results will be released after the close of market on Tuesday, November 3, 2026. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and insti.

PRNewsWire·Oct 7, 2026
USANA Health Sciences and University of Utah Athletics Announce New Partnership

Utah-based organizations unite to support more than 500 student-athletes across 19 sports SALT LAKE CITY, Oct. 7, 2026 /PRNewswire/ -- USANA Health Sciences and University of Utah Athletics have announced a new partnership bringing together two Utah organizations with a shared commitment to health, performance, and excellence. Through the partnership, USANA will support more than 500 University of Utah student-athletes across 19 sports, significantly expanding the company's global roster of sponsored, elite athletes and teams.

PRNewsWire·Oct 1, 2026
USANA CEO Kevin Guest Shares Three Ways to Celebrate International Music Day

SALT LAKE CITY, Oct. 1, 2026 /PRNewswire/ -- In recognition of International Music Day on Oct. 1, USANA Health Sciences (NYSE: USNA) Chairman and CEO Kevin Guest is urging people to experience music as a force that can reduce stress, lift spirits and connect people across cultures. International Music Day celebrates the world's diverse musical traditions and music's ability to advance peace, friendship, and mutual appreciation.

Zacks Investment Research·Sep 14, 2026
Implied Volatility Surging for USANA Health Stock Options

Investors need to pay close attention to USNA stock based on the movements in the options market lately.

Filtered for USANA Health Sciences, Inc.More Headlines
04

Compare before deciding

Benchmark USNA against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for USANA Health Sciences, Inc. (USNA)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
USNA logoUSNAUSANA Health Sciences, Inc.Current
$13.63$251.65M-11.898.28%-2.34%-3.65%—
NUS logoNUSNu Skin Enterprises, Inc.
$4.10$199.06M-0.85-14.26%-17.72%-34.83%5.74%
NATR logoNATRNature's Sunshine Products, Inc.
$10.87$191.15M13.265.67%3.05%8.76%—
NHTC logoNHTCNatural Health Trends Corp.
$0.77$8.03M-4.63-7.42%-4.18%-8.13%100%
HLF logoHLFHerbalife Nutrition Ltd.
$15.28$1.58B9.210.89%3.37%——
PLBY logoPLBYPlayboy, Inc.
$1.29$149.6M81.134.13%1.32%6.54%—

Compare USNA vs Peers

USANA Health Sciences, Inc. (USNA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NUS

Most directly comparable listed peer for USNA.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare USNA against a more recognizable public peer.

Peer Set

Compare Top 5

vs NUS, NATR, NHTC, HLF

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

USNA SEC Filings & Documents

USANA Health Sciences, Inc. (USNA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Aug 4, 2026·SEC

Material company update

May 20, 2026·SEC

Material company update

May 5, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 16, 2026·SEC

FY 2025

Mar 12, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

Aug 13, 2026·SEC

FY 2026

May 12, 2026·SEC

FY 2025

Nov 5, 2025·SEC

Get notified when USNA posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

USNA Frequently Asked Questions

USANA Health Sciences, Inc. (USNA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is USANA Health Sciences, Inc.'s revenue?

USANA Health Sciences, Inc. (USNA) reported $905.6M in revenue over the trailing twelve months. Revenue was $925.3M in fiscal year 2025. That is 1532% more than the $56.7M of fiscal year 1996.

How fast is USANA Health Sciences, Inc. growing?

USANA Health Sciences, Inc. (USNA) revenue fell by 0.8% over the trailing twelve months, compared with the twelve months before.

Is USNA profitable?

No. USANA Health Sciences, Inc. (USNA) reported a net loss of $21.2M over the trailing twelve months.

Dividend & Returns
What is USNA's return on equity?

USANA Health Sciences, Inc. (USNA) had a return on equity (ROE) of -3.7% over the trailing twelve months. A negative ROE means the company lost money over the period.

What is USANA Health Sciences, Inc.'s free cash flow?

USANA Health Sciences, Inc. (USNA) generated $8.5M in free cash flow in fiscal year 2025.

What if you invested $1,000 in USNA back in 1996?

Total return calculator · dividends reinvested · 30+ years of data

See returns →